SCHEMBL4481192

SCHEMBL4481192

COP(=O)(OC)C(N)C(C(=O)O)C(=O)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LAP3 P28838 2/20 0.44
KYNU Q16719 1/20 0.43
SLC15A1 P46059 2/20 0.42
SLC1A3 P43003 3/20 0.42
SLC1A1 P43005 3/20 0.42
SLC1A2 P43004 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ELANE P08246 1/20 0.41
CTSB P07858 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31244589 0.82 ALDH1A1 (0.50) ALDH1A1LAP3KYNUSLC15A1SLC1A3
SCHEMBL28012939 0.80 ALDH1A1 (0.50) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL10762480 0.79 ALDH1A1 (0.53) ALDH1A1LAP3KYNUKMT2AELANE
SCHEMBL27656879 0.79 ALDH1A1 (0.52) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL27591574 0.79 ALDH1A1 (0.52) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL14793800 0.78 ALDH1A1 (0.51) ALDH1A1LAP3KYNUKMT2AELANE
SCHEMBL7669860 0.77 SLC1A1 (0.58) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL27628195 0.77 ALDH1A1 (0.50) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL9110890 0.77 ALDH1A1 (0.50) ALDH1A1LAP3SLC15A1SLC1A3SLC1A1
SCHEMBL11170311 0.77 ALDH1A1 (0.44) ALDH1A1LAP3KYNUSLC15A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598241-B2 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors MERCK PATENT GMBH (DE) 2009-10-06 US disclosed
US-20060074072-A1 Carboxamide derivatives and their use as factor xa inhibitors MERCK PATENT GMBH (DE) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074072-A1 Carboxamide derivatives and their use as factor xa inhibitors F11, F12, F10 ALDH1A1 2219/4885LAP3 2696/4885KYNU 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.